Fuda Cancer Hospital – Lung Cancer Treatment Support for Indore Patients

If you are in Indore and searching for expert lung cancer treatment, Fuda Cancer Hospital provides advanced care. Fuda’s main hospital is located in Guangzhou, China. In India, Fuda partners with Rekosh Health Care to help patients with coordination, consultations and follow-up care. Although there is no full Fuda hospital in Indore, patients can access online consultations, personalised treatment plans and regular follow-up. For face-to-face visits, Fuda has two Consultation Centres in
India – Mumbai and Noida, where patients receive follow-up treatment, second opinions and palliative care. This setup lets Indore families access international cancer expertise with strong local support.

Helping Patients from Indore and Across Madhya Pradesh Access Advanced Cancer Care

Receiving a diagnosis of lung cancer can be overwhelming for both patients and their families. It often brings uncertainty, emotional stress, and many important questions. What type of lung cancer do I have? Has it spread? Is surgery necessary? Are there newer treatment options available? Should I seek a second opinion before beginning treatment?

For patients in Indore, these concerns are becoming increasingly common as lung cancer continues to be one of the leading causes of cancer-related illness worldwide. Fortunately, remarkable advances in cancer diagnosis and treatment have transformed the way lung cancer is managed. Today, specialists can develop highly personalised treatment plans based not only on the stage of cancer but also on the tumour’s genetic characteristics, overall health, and the individual needs of each patient.

Indore is one of the fastest-growing cities in Central India and serves as an important healthcare destination for patients from across Madhya Pradesh, including Ujjain, Dewas, Mhow, Pithampur, Dhar, Ratlam, Khandwa, Khargone, Burhanpur, Neemuch, Mandsaur, and neighbouring districts. Many patients also travel from nearby areas of Maharashtra, Rajasthan, and Chhattisgarh to seek specialised medical care.

With increasing urbanisation, industrial development, traffic-related air pollution, and continued tobacco use, the burden of respiratory diseases—including lung cancer—has gradually increased across the region. Smoking remains the most significant risk factor, but it is important to understand that lung cancer can also occur in people who have never smoked. Environmental pollution, second-hand smoke, occupational exposure to harmful chemicals, previous lung diseases, and certain genetic mutations may also contribute to the development of lung cancer.

Because the disease often develops silently during its early stages, many patients do not experience noticeable symptoms until the cancer has progressed. A persistent cough, unexplained breathlessness, chest pain, coughing up blood, repeated chest infections, or unexplained weight loss should never be ignored. Seeking medical advice early can lead to faster diagnosis and significantly improve treatment options.

Fuda Cancer Hospital, with its internationally recognised cancer centre in Guangzhou, China, works in collaboration with Rekosh Health Care in India to support patients seeking expert cancer consultation, multidisciplinary treatment planning, second opinions, and coordinated follow-up care. Patients from Indore can begin with an online consultation, upload their medical reports for expert review, and receive personalised recommendations from experienced oncology specialists. When required, in-person consultations can also be arranged through Fuda’s consultation centres in Mumbai and Noida.

Modern lung cancer treatment is no longer limited to surgery or chemotherapy alone. Depending on the diagnosis, treatment may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, Cryotherapy, NanoKnife Irreversible Electroporation (IRE), or a carefully planned combination of these approaches. Every treatment plan is developed after considering the type of lung cancer, its stage, genetic profile, overall health, and treatment goals.

This comprehensive guide has been specially prepared for patients from Indore and Madhya Pradesh who wish to understand lung cancer in greater detail. It explains the disease from diagnosis to recovery, discusses available treatment options, outlines modern advances in cancer care, and answers many of the questions commonly asked by patients and caregivers. Whether you have recently been diagnosed, are looking for a second opinion, or want to learn more about advanced lung cancer treatment, this guide aims to provide clear, reliable, and patient-friendly information to help you make informed healthcare decisions.

Why Lung Cancer Is Becoming a Growing Health Concern in Indore

Lung cancer is no longer confined to older smokers or industrial workers. Across Madhya Pradesh, including Indore, doctors are seeing increasing numbers of patients with lung cancer due to a combination of lifestyle, environmental, and genetic factors. Early recognition of these risks plays an important role in prevention and timely diagnosis.

Smoking and Tobacco Use

Cigarette smoking remains the leading cause of lung cancer worldwide. In addition to cigarettes, the use of beedis and other tobacco products continues to contribute significantly to lung disease in many parts of Central India. Long-term exposure to tobacco smoke damages the cells lining the lungs, increasing the likelihood of cancer developing over time.

Air Pollution

As Indore has grown into a major commercial and industrial city, exposure to vehicle emissions, construction dust, and environmental pollution has also increased. Although air pollution alone does not cause every case of lung cancer, prolonged exposure to fine particulate matter may contribute to chronic lung inflammation and increase the overall risk, especially in people with other predisposing factors.

Occupational Exposure

Workers employed in industries such as manufacturing, construction, mining, engineering, transportation, and chemical processing may be exposed to substances including asbestos, silica dust, diesel exhaust, and industrial chemicals. Long-term occupational exposure without appropriate protective measures has been associated with a higher risk of lung cancer.

Previous Lung Diseases

Individuals with chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), pulmonary fibrosis, or a previous history of tuberculosis may have an increased risk of developing lung cancer later in life. Persistent respiratory symptoms in these patients should always be evaluated carefully.

Family History and Genetics

Although smoking remains the most important risk factor, genetics also play an important role. Some patients develop lung cancer despite never smoking because of inherited susceptibility or acquired genetic mutations within lung cells.

Increasing Age

The majority of lung cancer cases occur in adults over the age of 50, although younger individuals can also develop the disease. Advancing age, combined with long-term exposure to environmental and lifestyle-related risk factors, increases the overall likelihood of diagnosis.

Early diagnosis remains one of the most effective ways to improve treatment outcomes. Patients experiencing persistent respiratory symptoms should seek timely medical evaluation rather than assuming the symptoms are caused by pollution, ageing, or seasonal illness.

Understanding the Lungs

The lungs are among the most important organs in the human body. They continuously supply oxygen to the bloodstream while removing carbon dioxide produced during normal metabolism. Every breath we take allows oxygen to reach the heart, brain, muscles, and every other organ necessary for life.

The right lung is divided into three lobes, while the left lung contains two lobes to accommodate the heart. Air enters through the nose or mouth, travels down the trachea (windpipe), passes through the bronchi, and finally reaches millions of tiny air sacs called alveoli. Within these air sacs, oxygen enters the bloodstream and carbon dioxide is removed from the body during exhalation.

Because the lungs remain in constant contact with the outside environment, they are continuously exposed to cigarette smoke, air pollution, dust, industrial chemicals, infectious organisms, and other airborne particles. Over many years, repeated exposure to harmful substances can damage the DNA of normal lung cells. When this damage accumulates, some cells may begin growing uncontrollably, eventually forming a tumour.

The lungs are also closely connected to blood vessels and lymphatic channels, allowing untreated lung cancer to spread to nearby lymph nodes and distant organs such as the brain, liver, bones, or adrenal glands. This is one of the reasons why early diagnosis and timely treatment are so important.

What Is Lung Cancer?

Lung cancer is a disease in which abnormal cells within the lungs begin to grow uncontrollably, eventually forming a tumour. Unlike healthy cells that grow, divide, and die in a regulated manner, cancer cells continue multiplying without control. Over time, these abnormal cells can invade nearby tissues, block normal airways, and spread to distant organs through the bloodstream or lymphatic system.

The lungs are responsible for delivering oxygen to the body and removing carbon dioxide. Because they are constantly exposed to the outside environment, they come into contact with cigarette smoke, air pollution, industrial chemicals, dust particles, and infectious organisms every day. Continuous exposure to these harmful substances can damage the DNA of lung cells. When the body’s natural repair mechanisms fail to correct this damage, mutations accumulate and may eventually lead to the development of lung cancer.

One of the biggest challenges with lung cancer is that it often develops silently. Small tumours may not cause any symptoms, allowing the disease to progress unnoticed. As the tumour enlarges or spreads, patients may begin experiencing symptoms such as a persistent cough, chest pain, breathlessness, coughing up blood, hoarseness, unexplained weight loss, or repeated chest infections.

Fortunately, lung cancer treatment has advanced significantly over the past two decades. Earlier diagnosis, improved imaging techniques, molecular testing, targeted therapy, immunotherapy, minimally invasive procedures, and multidisciplinary cancer care have greatly expanded treatment options for many patients. Today, treatment is increasingly personalised, offering patients therapies tailored to the specific characteristics of their cancer.

Types of Lung Cancer

Lung cancer is not a single disease. It is classified into different types based on the appearance of cancer cells under the microscope and their biological behaviour. Identifying the exact type of lung cancer is essential because treatment options, prognosis, and response to therapy vary considerably.

Modern cancer care also includes molecular profiling, which helps identify specific genetic mutations that may respond to targeted therapy.

Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer (NSCLC) accounts for nearly 85% of all lung cancer cases and is generally slower growing than Small Cell Lung Cancer.

Because NSCLC often develops gradually, patients diagnosed during the early stages may be suitable candidates for surgery or other curative treatments.

NSCLC is divided into three major subtypes.

Adenocarcinoma

Adenocarcinoma is the most common type of lung cancer worldwide. It usually develops in the outer portions of the lungs and is increasingly diagnosed in people who have never smoked.

This subtype frequently contains genetic mutations such as EGFR, ALK, ROS1, KRAS, or BRAF, making molecular testing extremely important before treatment planning.

Symptoms may include:

• Persistent cough
• Breathlessness
• Chest discomfort
• Fatigue
• Weight loss

Treatment depends on the stage of disease and may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or a combination of these approaches.

Squamous Cell Carcinoma

Squamous Cell Carcinoma usually develops within the larger airways of the lungs and has a strong association with long-term tobacco smoking.

Patients commonly present with:

• Persistent cough
• Blood in sputum
• Chest pain
• Wheezing
• Recurrent chest infections

If diagnosed early, surgery may be recommended. More advanced disease often requires chemotherapy, radiation therapy, or immunotherapy.

Large Cell Carcinoma

Large Cell Carcinoma is a less common subtype of NSCLC.

It may develop anywhere within the lungs and often grows more rapidly than adenocarcinoma or squamous cell carcinoma.

Treatment depends on:

• Tumour size
• Stage
• Overall health
• Molecular profile

Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer accounts for approximately 10–15% of all lung cancer cases.

Unlike NSCLC, SCLC tends to grow rapidly and spread early to organs such as the brain, liver, adrenal glands, and bones.

Because of its aggressive nature, surgery is less commonly performed. Treatment usually involves:

• Chemotherapy
• Radiation therapy
• Immunotherapy in selected patients

Although aggressive, SCLC often responds well to initial treatment, highlighting the importance of early diagnosis and prompt treatment.

Metastatic Lung Cancer

Metastatic lung cancer refers to cancer that has spread beyond the lungs.

Common sites include:

• Brain
• Liver
• Bones
• Adrenal glands
• Distant lymph nodes

While metastatic disease is generally more complex to treat, advances in targeted therapy, immunotherapy, supportive care, and personalised medicine have significantly improved quality of life and survival for many patients.

Early Symptoms of Lung Cancer

One of the biggest reasons lung cancer is diagnosed at an advanced stage is that its early symptoms are often mistaken for common respiratory illnesses such as bronchitis, seasonal allergies, or asthma.

Patients from Indore frequently delay seeking medical attention because they believe symptoms are related to pollution, smoking, or changing weather.

If symptoms persist for more than two to three weeks, medical evaluation is strongly recommended.

Persistent Cough

A cough that lasts for several weeks or gradually becomes worse is one of the earliest warning signs of lung cancer.

Many smokers already have a chronic cough and may overlook changes in its frequency or severity. However, any noticeable change in a long-standing cough should be evaluated promptly.

Coughing Up Blood

Even small amounts of blood in sputum should never be ignored.

Although infections may occasionally cause blood-stained sputum, coughing up blood can also indicate lung cancer and requires immediate medical assessment.

Chest Pain

Persistent chest pain that worsens while coughing, laughing, or taking deep breaths may indicate that a tumour is affecting the lining of the lungs or nearby structures.

Unlike muscle pain, this discomfort often does not improve with routine pain medications.

Shortness of Breath

As a tumour enlarges, it may partially block the airways or reduce normal lung function.

Patients often notice breathlessness during activities such as climbing stairs, walking short distances, or carrying groceries.

Wheezing

A new wheezing sound during breathing, particularly in someone without asthma, should be investigated.

Tumours located within the airways may restrict airflow and produce a whistling sound while breathing.

Hoarseness

Cancer affecting nerves that control the vocal cords may lead to persistent hoarseness or changes in voice quality.

Hoarseness lasting more than three weeks should not be ignored.

Recurrent Chest Infections

Repeated episodes of pneumonia or bronchitis involving the same area of the lung may indicate an underlying tumour blocking the airway.

Fatigue

Many patients experience overwhelming tiredness that is not relieved by rest.

Cancer-related fatigue differs from ordinary tiredness and may interfere significantly with daily activities.

Unexplained Weight Loss

Unexpected weight loss without dieting or increased exercise is an important warning sign.

Patients may also experience:

• Reduced appetite
• Muscle loss
• Weakness
• Early satiety

Bone Pain

If lung cancer spreads to the bones, patients may develop persistent pain involving:

• Spine
• Ribs
• Shoulders
• Hips

Persistent bone pain should always be evaluated by a healthcare professional.

Headaches and Neurological Symptoms

Cancer that spreads to the brain may produce:

• Persistent headaches
• Dizziness
• Weakness
• Vision problems
• Difficulty walking
• Seizures

These symptoms require urgent medical evaluation.

Causes and Risk Factors

Lung cancer develops because of a combination of environmental exposure, lifestyle habits, ageing, and genetic changes.

Smoking remains the leading cause, but a growing number of patients diagnosed today have never smoked.

Major risk factors include:

• Cigarette smoking
• Beedi smoking
• Second-hand smoke
• Air pollution
• Industrial dust
• Asbestos exposure
• Radon gas
• Diesel exhaust
• Previous tuberculosis
• COPD
• Pulmonary fibrosis
• Family history of lung cancer
• Increasing age
• Genetic mutations

Understanding these risk factors helps identify individuals who may benefit from earlier medical evaluation and, in appropriate cases, screening.

Who Is at Higher Risk?

People who should pay particular attention to persistent respiratory symptoms include:

• Current smokers
• Former smokers
• Adults over 50 years of age
• Individuals exposed to second-hand smoke
• Workers in mining, construction, manufacturing, or chemical industries
• People with COPD or previous tuberculosis
• Individuals with a family history of lung cancer
• Those living in areas with prolonged exposure to air pollution

Recognising these risks does not mean that a person will definitely develop lung cancer, but it highlights the importance of regular medical check-ups, timely investigation of symptoms, and discussions with a healthcare professional regarding appropriate screening where indicated.

When Should You Consult a Lung Cancer Specialist?

Many people delay seeking medical attention because they believe a persistent cough or breathing difficulty is simply caused by smoking, air pollution, allergies, or a seasonal infection. Unfortunately, this delay may allow lung cancer to progress before it is diagnosed.

Early detection remains one of the most important factors influencing treatment success. When lung cancer is diagnosed at an earlier stage, patients often have access to more treatment options and may achieve better long-term outcomes.

If you live in Indore or nearby cities such as Ujjain, Dewas, Dhar, Mhow, Ratlam, Khandwa, Burhanpur, or Khargone, you should consult a doctor if you experience any of the following symptoms for more than two to three weeks:

• A cough that does not improve or continues to worsen
• Coughing up blood or blood-stained sputum
• Persistent chest pain
• Shortness of breath during routine activities
• Hoarseness of voice
• Repeated chest infections
• Unexplained weight loss
• Persistent fatigue
• Wheezing without a history of asthma
• Bone pain or neurological symptoms associated with respiratory complaints

Seeking medical advice early does not necessarily mean you have lung cancer, but it helps identify the cause of your symptoms and allows timely treatment if required.

How Is Lung Cancer Diagnosed?

Diagnosing lung cancer requires more than simply identifying a tumour on an X-ray. Modern diagnosis combines advanced imaging, tissue biopsy, laboratory testing, and molecular analysis to determine the exact type of cancer, its stage, and the most suitable treatment approach.

Patients from Indore can undergo many of these investigations locally before obtaining an expert review or second opinion if needed.

Medical History and Physical Examination

Every evaluation begins with a detailed consultation.

Your doctor may ask questions regarding:

• Duration of symptoms
• Smoking history
• Occupational exposure
• Previous tuberculosis or lung disease
• Family history of cancer
• Current medications
• Existing medical conditions
• Weight loss
• Appetite changes
• Previous cancer treatment

A thorough physical examination may also reveal enlarged lymph nodes, abnormal breath sounds, reduced oxygen levels, or other signs requiring additional investigation.

Chest X-Ray

A chest X-ray is often the first imaging investigation recommended when lung cancer is suspected.

Although a chest X-ray cannot diagnose every lung tumour, it can identify several abnormalities including:

• Lung masses
• Lung collapse
• Fluid accumulation around the lungs
• Enlarged lymph nodes
• Persistent pneumonia

If abnormalities are detected, additional imaging is usually recommended.

CT Scan (Computed Tomography)

A CT scan provides highly detailed cross-sectional images of the chest and is considered one of the most important investigations in lung cancer diagnosis.

Compared with a standard chest X-ray, CT imaging provides significantly greater detail.

It helps doctors determine:

• Exact tumour location
• Tumour size
• Involvement of nearby structures
• Enlarged lymph nodes
• Relationship to major blood vessels
• Possible spread within the chest

CT scans also help specialists decide whether surgery, biopsy, or other procedures are appropriate.

PET-CT Scan

A PET-CT scan combines Positron Emission Tomography (PET) with Computed Tomography (CT) to provide both anatomical and functional information.

Before the scan, a small amount of radioactive glucose is injected into the bloodstream.

Because cancer cells generally consume more glucose than normal tissues, they appear as areas of increased activity during imaging.

PET-CT helps determine:

• Whether cancer has spread beyond the lungs
• Involvement of lymph nodes
• Suitability for surgery
• Response to treatment
• Possible recurrence after therapy

PET-CT has become one of the most valuable investigations in modern lung cancer staging.

MRI Scan

MRI scans are generally recommended when specialists suspect that lung cancer has spread to the brain, spine, or other soft tissues.

Unlike CT, MRI provides excellent visualisation of the nervous system and is frequently used in patients with neurological symptoms such as headaches, weakness, dizziness, or seizures.

Bronchoscopy

Bronchoscopy is a minimally invasive procedure that allows doctors to examine the inside of the airways using a thin flexible tube fitted with a camera.

During bronchoscopy, specialists can:

• Visualise the airways
• Identify abnormal growths
• Collect tissue samples
• Remove secretions if necessary
• Assess airway narrowing

The procedure is usually performed under local anaesthesia with sedation and most patients return home the same day.

Endobronchial Ultrasound (EBUS)

Endobronchial Ultrasound combines bronchoscopy with ultrasound imaging.

This advanced technique allows doctors to evaluate lymph nodes deep within the chest and obtain biopsy samples without the need for open surgery.

EBUS plays an important role in accurate staging and treatment planning.

CT-Guided Needle Biopsy

When a tumour is located near the outer portion of the lung, a CT-guided needle biopsy may be recommended.

Using CT images for guidance, a specialised needle is inserted through the chest wall to obtain a small tissue sample.

The sample is examined under a microscope to confirm the diagnosis.

Histopathology

A biopsy remains the gold standard for confirming lung cancer.

The pathology report provides detailed information regarding:

• Type of lung cancer
• Tumour grade
• Cell characteristics
• Additional features that influence treatment planning

Without a biopsy, it is generally not possible to make a definitive diagnosis of lung cancer.

Molecular Testing

One of the biggest advances in modern oncology is molecular profiling.

Rather than simply identifying the tumour under a microscope, specialists now analyse genetic alterations within the cancer cells.

Common biomarkers include:

• EGFR
• ALK
• ROS1
• KRAS
• BRAF
• RET
• MET
• NTRK
• PD-L1

If these biomarkers are present, patients may benefit from targeted therapy or immunotherapy.

Molecular testing has become an essential part of personalised lung cancer treatment and is recommended for many patients with Non-Small Cell Lung Cancer.

Liquid Biopsy

Liquid biopsy is a newer blood test that detects fragments of tumour DNA circulating in the bloodstream.

It may be recommended:

• When tissue biopsy is difficult
• To identify additional genetic mutations
• To monitor treatment response
• To evaluate suspected recurrence

Although not suitable for every patient, liquid biopsy has become an increasingly useful tool in precision oncology.

Understanding Lung Cancer Staging

After confirming the diagnosis, specialists determine how far the cancer has spread.

This process is called staging.

Accurate staging is essential because treatment recommendations differ significantly between early-stage and advanced disease.

Stage 0

Cancer cells remain confined to the lining of the airways without invading deeper tissues.

Treatment at this stage often offers excellent long-term outcomes.

Stage I

The tumour is confined to the lung and has not spread to nearby lymph nodes.

Many patients diagnosed at this stage are suitable candidates for surgery or other local treatments with curative intent.

Stage II

The tumour may be larger or involve nearby lymph nodes.

Treatment often includes surgery followed by chemotherapy and, in selected cases, radiation therapy.

Stage III

Cancer has spread to lymph nodes within the chest or nearby structures.

Management usually involves a combination of:

• Chemotherapy
• Radiation therapy
• Immunotherapy
• Surgery in carefully selected patients

Treatment decisions require multidisciplinary discussion.

Stage IV

Stage IV lung cancer indicates that the disease has spread beyond the lungs to distant organs such as the brain, liver, bones, or adrenal glands.

Although Stage IV disease is generally not considered curable, many patients now benefit from personalised treatment using targeted therapy, immunotherapy, chemotherapy, supportive care, or combinations of these treatments.

Personalised Treatment Planning

Every lung cancer diagnosis is unique.

Specialists develop treatment recommendations after carefully considering:

• Type of lung cancer
• Stage of disease
• Molecular profile
• Patient’s age
• General health
• Lung function
• Previous treatments
• Personal treatment goals

Patients from Indore seeking a second opinion through Fuda Cancer Hospital can have their CT scans, PET-CT images, biopsy reports, and molecular testing reviewed by an experienced multidisciplinary oncology team. This collaborative approach helps ensure that every patient receives an evidence-informed, individualised treatment plan tailored to their specific diagnosis and overall clinical condition before treatment begins.

Advanced Treatment Options for Lung Cancer

Lung cancer treatment has advanced significantly over the last two decades. Today, doctors no longer rely on a single treatment method for every patient. Instead, each treatment plan is personalised after considering the type of lung cancer, its stage, genetic characteristics, overall health, lung function, and the patient’s personal goals.

For many patients in Indore and across Madhya Pradesh, understanding all available treatment options is an important part of making informed healthcare decisions. Some patients may benefit from surgery alone, while others may require a combination of chemotherapy, radiation therapy, immunotherapy, targeted therapy, or minimally invasive procedures.

A multidisciplinary team carefully reviews every case to determine the most appropriate treatment strategy.

Surgery for Lung Cancer

Surgery remains one of the most effective treatment options for patients diagnosed with early-stage Non-Small Cell Lung Cancer (NSCLC). The goal of surgery is to remove the tumour completely while preserving as much healthy lung tissue as possible.

Before recommending surgery, doctors evaluate:

• Stage of lung cancer
• Tumour size and location
• Lung function
• Heart function
• General health
• Other medical conditions

Not every patient requires removal of the entire lung. Modern thoracic surgery aims to preserve normal lung tissue whenever possible while achieving complete removal of the cancer.

Types of Surgery

Wedge Resection

A wedge resection removes the tumour together with a small margin of surrounding healthy lung tissue.

It may be considered for:

• Very small tumours
• Patients with reduced lung capacity
• Early-stage cancers
• Patients unsuitable for major surgery

Because less lung tissue is removed, recovery is often quicker.

Segmentectomy

The lungs are divided into several anatomical segments.

A segmentectomy removes only the affected segment rather than an entire lobe.

This allows surgeons to preserve more healthy lung tissue while still providing effective cancer treatment for selected patients.

Lobectomy

A lobectomy involves removal of one complete lobe of the lung.

It is considered the standard surgical treatment for many early-stage lung cancers because it provides excellent long-term cancer control when the disease remains confined to one lobe.

Pneumonectomy

If the tumour involves a major airway or occupies a large portion of the lung, removal of the entire lung may occasionally be necessary.

Although this is a major operation, many patients continue to lead active lives after recovery with appropriate rehabilitation and follow-up care.

Chemotherapy

Chemotherapy uses specialised anti-cancer medicines to destroy rapidly dividing cancer cells throughout the body.

It may be recommended:

• Before surgery to shrink the tumour (Neoadjuvant Chemotherapy)
• After surgery to reduce the risk of recurrence (Adjuvant Chemotherapy)
• Alongside radiation therapy
• For advanced or metastatic lung cancer
• To help relieve symptoms and improve quality of life in selected patients

Treatment is usually given in cycles, allowing the body time to recover between sessions.

The number of cycles depends on:

• Cancer stage
• Treatment response
• Overall health
• Individual treatment plan

Possible Side Effects

Modern supportive medications have greatly improved the management of chemotherapy-related side effects.

Some patients may experience:

• Fatigue
• Nausea and vomiting
• Temporary hair loss
• Reduced immunity
• Mouth ulcers
• Loss of appetite
• Tingling or numbness in the hands and feet

Not every patient experiences all side effects, and many can be managed effectively with supportive care.

Radiation Therapy

Radiation therapy uses precisely targeted high-energy radiation to destroy cancer cells while minimising damage to surrounding healthy tissues.

It may be recommended:

• As the primary treatment for patients who cannot undergo surgery
• Before surgery to shrink a tumour
• After surgery to reduce the risk of recurrence
• Along with chemotherapy
• To relieve symptoms caused by advanced cancer

Modern radiation therapy techniques have become increasingly accurate, allowing doctors to target tumours more effectively.

Intensity-Modulated Radiation Therapy (IMRT)

IMRT delivers radiation from multiple angles while adjusting the intensity of each beam.

This allows specialists to maximise the radiation dose to the tumour while reducing exposure to healthy tissues such as the heart, spinal cord, and healthy lung.

Stereotactic Body Radiation Therapy (SBRT)

SBRT delivers very high doses of radiation with exceptional precision over a small number of treatment sessions.

It may be suitable for selected patients with small, localised lung tumours who are not candidates for surgery.

Targeted Therapy

Targeted therapy has transformed the treatment of many patients with Non-Small Cell Lung Cancer.

Unlike chemotherapy, targeted therapy specifically attacks cancer cells with certain genetic mutations while causing less damage to many normal cells.

Before treatment, molecular testing is performed to identify biomarkers such as:

• EGFR
• ALK
• ROS1
• KRAS
• MET
• RET
• BRAF
• NTRK

Patients whose tumours carry these mutations may benefit from medicines designed to block the abnormal signals that help cancer cells grow.

Potential Advantages

• Precision-based treatment
• Often available as oral medication
• Different side-effect profile compared with chemotherapy
• Improved disease control in selected patients
• Personalised treatment approach

Not every patient is eligible, which is why comprehensive molecular testing has become an important part of modern lung cancer care.

Immunotherapy

Immunotherapy is one of the most significant advances in cancer treatment over recent years.

Rather than directly attacking cancer cells, immunotherapy helps the body’s own immune system recognise and destroy them.

Some cancer cells produce proteins that allow them to hide from immune cells. Immunotherapy blocks these protective mechanisms, enabling the immune system to identify and attack the tumour more effectively.

Before treatment, doctors may perform PD-L1 testing or other biomarker assessments to determine whether immunotherapy is likely to be beneficial.

Immunotherapy may be recommended:

• Alone
• Combined with chemotherapy
• Following chemotherapy and radiation therapy
• For advanced or metastatic lung cancer
• In selected patients after surgery

Responses vary from person to person, but immunotherapy has significantly improved long-term outcomes for many eligible patients.

Cryotherapy (Cryosurgery)

Cryotherapy, also known as Cryosurgery or Cryoablation, is a minimally invasive technique that destroys cancer cells using extremely low temperatures.

Using advanced imaging guidance, a specialised probe is placed within or close to the tumour. Controlled freezing and thawing cycles damage the cancer cells while helping preserve surrounding healthy tissue.

Potential benefits include:

• Minimally invasive treatment
• Small skin puncture instead of a large surgical incision
• Reduced blood loss
• Faster recovery
• Preservation of surrounding lung tissue in selected patients

Cryotherapy is not suitable for every patient. The decision depends on tumour size, location, stage, and overall clinical assessment.

NanoKnife Irreversible Electroporation (IRE)

NanoKnife IRE is an advanced treatment that uses carefully controlled electrical pulses instead of heat or freezing to destroy cancer cells.

These electrical pulses create microscopic openings in the cancer cell membrane, leading to cell death while helping preserve nearby blood vessels, nerves, and other important structures.

Because of this unique mechanism, NanoKnife IRE may be considered for selected patients whose tumours are located close to vital structures where conventional surgery or thermal ablation may be challenging.

Potential advantages include:

• Minimally invasive procedure
• Precision targeting of selected tumours
• Preservation of surrounding healthy structures
• Shorter recovery in appropriately selected patients
• Integration into personalised treatment plans

Suitability is determined after careful multidisciplinary evaluation.

Recovery and Rehabilitation

Recovery from lung cancer treatment varies depending on the type of therapy received and the patient’s overall health.

Important aspects of recovery include:

• Pulmonary rehabilitation
• Breathing exercises
• Gradual return to physical activity
• Smoking cessation
• Nutritional support
• Regular follow-up imaging
• Symptom monitoring
• Emotional support

A structured rehabilitation programme can improve lung function, reduce fatigue, and help patients regain confidence in daily activities.

Nutrition During Lung Cancer Treatment

Good nutrition supports healing, helps maintain muscle strength, and enables the body to tolerate treatment more effectively.

General recommendations include:

• Eat small, frequent meals throughout the day.
• Include protein-rich foods such as eggs, fish, lean meat, pulses, paneer, tofu, and dairy products.
• Consume a variety of fruits and vegetables rich in vitamins and antioxidants.
• Drink adequate fluids to maintain hydration.
• Limit processed foods, excessive sugar, and alcohol.
• Seek guidance from a clinical dietitian if swallowing becomes difficult or appetite decreases significantly.

Every patient’s nutritional requirements are different, particularly during chemotherapy or radiation therapy, and personalised dietary advice may be beneficial.

Why Patients from Indore Choose Fuda Cancer Hospital

Patients from Indore and neighbouring cities often seek a second opinion when they wish to better understand their diagnosis or explore advanced treatment options.

Through its collaboration with Rekosh Health Care in India, Fuda Cancer Hospital provides:

• Expert second-opinion services
• Multidisciplinary case discussions
• Personalised treatment planning
• Review of imaging and pathology reports
• Guidance on advanced therapies
• Follow-up care coordination
• Consultation support through centres in Mumbai and Noida

This collaborative approach helps patients and families make informed treatment decisions based on their individual diagnosis, overall health, and treatment goals.

Treatment Journey for Patients from Indore

A lung cancer diagnosis can feel overwhelming, but having a clear understanding of the treatment process helps patients and their families prepare for the journey ahead. Through Rekosh Health Care, patients from Indore can access expert guidance from Fuda Cancer Hospital and receive support at every stage of their care.

Step 1 – Schedule an Expert Consultation

The first step is to book an online or in-person consultation. During this consultation, the medical team reviews your symptoms, previous treatments, and current medical condition while discussing your concerns and expectations.

Step 2 – Share Medical Reports

Patients are encouraged to submit all relevant investigations, including:

• Chest X-ray
• CT Scan
• PET-CT Scan
• MRI (if available)
• Bronchoscopy reports
• Biopsy report
• Histopathology report
• Molecular testing reports
• Previous treatment records

These documents help specialists understand the disease accurately before recommending further management.

Step 3 – Comprehensive Medical Review

The multidisciplinary team carefully evaluates:

• Cancer type
• Disease stage
• Genetic profile
• Overall health
• Lung function
• Previous treatment history

Based on this assessment, a personalised treatment strategy is prepared.

Step 4 – Personalised Treatment Planning

Every patient receives an individualised treatment recommendation, which may include:

• Surgery
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Immunotherapy
• Cryotherapy
• NanoKnife IRE
• Supportive and Palliative Care

Patients and their families are guided through each recommendation so they can make informed decisions.

Step 5 – Follow-up Care

Regular follow-up remains an essential part of lung cancer management.

Follow-up may include:

• Clinical examinations
• CT or PET-CT scans
• Blood investigations
• Symptom assessment
• Medication review
• Nutritional counselling
• Pulmonary rehabilitation
• Lifestyle guidance

Long-term follow-up helps monitor recovery, evaluate treatment response, and detect recurrence as early as possible.

Lung Cancer Treatment Cost in Indore

The cost of lung cancer treatment varies depending on several factors, including the stage of disease, investigations required, treatment modality, hospital stay, medications, and supportive care.

Approximate Diagnostic Costs

Approximate Treatment Costs

These figures are approximate estimates. The final cost depends on the patient’s diagnosis, treatment plan, duration of hospital stay, medications, and overall medical condition.

Can Lung Cancer Be Prevented?

Although lung cancer cannot always be prevented, several healthy lifestyle measures can reduce the overall risk.

Stop Smoking

Smoking remains the leading cause of lung cancer. Quitting smoking at any age can reduce future risk and improve overall health.

Avoid Second-Hand Smoke

Exposure to passive smoking also increases the risk of lung cancer. Maintaining smoke-free homes and workplaces is beneficial.

Reduce Exposure to Air Pollution

Avoid prolonged exposure to industrial dust, vehicle emissions, and environmental pollution whenever possible. Use appropriate protective equipment in occupational settings.

Maintain a Healthy Lifestyle

A balanced diet, regular exercise, adequate sleep, and maintaining a healthy body weight contribute to better lung health.

Regular Health Check-ups

People with significant smoking history, occupational exposure, or chronic lung disease should discuss appropriate screening and regular health evaluations with their doctor.

Frequently Asked Questions (FAQs)

1. Can non-smokers develop lung cancer?

Yes. Lung cancer can occur in non-smokers due to genetic factors, passive smoking, air pollution, occupational exposure, previous lung diseases, or environmental toxins.

2. What are the earliest symptoms of lung cancer?

Common early symptoms include a persistent cough, breathlessness, chest pain, coughing up blood, hoarseness, repeated chest infections, fatigue, and unexplained weight loss.

3. Is lung cancer curable?

Some early-stage lung cancers can be treated with curative intent. Outcomes depend on the type of cancer, stage at diagnosis, overall health, and response to treatment.

4. Is surgery required for every patient?

No. Treatment depends on the stage and type of lung cancer. Many patients are treated with chemotherapy, radiation therapy, immunotherapy, targeted therapy, or combinations of these treatments.

5. What is molecular testing?

Molecular testing identifies genetic mutations such as EGFR, ALK, ROS1, KRAS, and others that may help determine whether targeted therapy is suitable.

6. What is targeted therapy?

Targeted therapy uses medicines that specifically attack cancer cells carrying certain genetic mutations while minimising damage to many normal cells.

7. What is immunotherapy?

Immunotherapy helps the body’s immune system recognise and destroy cancer cells. It may be recommended for selected patients depending on tumour characteristics.

8. What is Cryotherapy?

Cryotherapy (Cryoablation) is a minimally invasive procedure that destroys selected tumours using extremely low temperatures.

9. What is NanoKnife IRE?

NanoKnife Irreversible Electroporation (IRE) is a minimally invasive treatment that uses electrical pulses to destroy selected tumours while helping preserve nearby blood vessels and nerves.

10. Can I get a second opinion before starting treatment?

Yes. Many patients seek a second opinion to better understand their diagnosis, explore available treatment options, and make informed decisions before beginning therapy.

11. Can treatment begin after an online consultation?

Many patients begin with an online consultation and report review. Further investigations or in-person assessments are arranged only if required.

12. Which reports should I keep ready?

CT scan, PET-CT scan, biopsy report, pathology report, molecular testing results, blood investigations, and previous treatment records are helpful for review.

13. Can lung cancer spread to other organs?

Yes. If not treated, lung cancer may spread to the brain, liver, bones, adrenal glands, or distant lymph nodes.

14. How often is follow-up required?

The follow-up schedule varies depending on the treatment received and individual medical condition. Your treating doctor will recommend an appropriate follow-up plan.

15. Can people continue working during treatment?

Some patients continue working during treatment, while others require temporary leave. This depends on the treatment type, side effects, and overall health.

Conclusion

Lung cancer is a complex disease, but advances in medical science have greatly improved diagnosis, treatment, and long-term care. Early detection, accurate staging, molecular testing, and personalised treatment planning allow many patients to benefit from therapies that were not available just a few years ago.

For patients in Indore and across Madhya Pradesh, understanding the disease and seeking timely expert advice are essential first steps. Whether you have recently been diagnosed, require a second opinion, or wish to explore advanced treatment options, discussing your case with an experienced multidisciplinary oncology team can help you make informed decisions with confidence.

Schedule Your Consultation

If you or a loved one has been diagnosed with lung cancer, you can begin by requesting an expert consultation through Rekosh Health Care, the official India partner supporting patient coordination with Fuda Cancer Hospital.

The team can assist with:

• Expert second opinions
• Medical report review
• Personalised treatment planning
• Guidance on advanced treatment options
• Coordination of consultations and follow-up care
• Answers to treatment-related questions

Early consultation and timely medical evaluation can make a significant difference in selecting the most appropriate treatment strategy. Taking the first step today may help you better understand your diagnosis and explore the options available for your individual situation.